XML 14 R4.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]    
Technology development and licensing revenue $ 125,000 $ 125,000
Operating expenses:    
Research and development 2,571,573 3,052,049
General and administrative 2,936,771 1,838,906
Total operating expenses 5,508,344 4,890,995
Loss from operations (5,383,344) (4,765,955)
Other income (expense):    
Loss from change in valuation of earn-out milestone liability (151,000) (41,274)
Investment income 2,411 88,309
Interest expense (157,614) (339,365)
Other income 544 1,407
Total other income (expense), net (305,659) (290,923)
Net loss $ (5,689,003) $ (5,056,878)
Net loss per common share - Basic and diluted $ (0.09) $ (0.20)
Weighted average shares outstanding - Basic and diluted 66,298,723 25,804,349